SG Americas Securities’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $730K | Buy |
36,373
+23,261
| +177% | +$467K | ﹤0.01% | 1250 |
|
|
2025
Q1 | $258K | Sell |
13,112
-3,517
| -21% | -$69.2K | ﹤0.01% | 2089 |
|
|
2024
Q4 | $374K | Buy |
16,629
+6,616
| +66% | +$149K | ﹤0.01% | 1407 |
|
|
2024
Q3 | $256K | Buy |
+10,013
| New | +$256K | ﹤0.01% | 2023 |
|
|
2024
Q2 | – | Sell |
-9,430
| Closed | -$166K | – | 2534 |
|
|
2024
Q1 | $166K | Sell |
9,430
-4,071
| -30% | -$71.7K | ﹤0.01% | 1882 |
|
|
2023
Q4 | $187K | Buy |
13,501
+2,041
| +18% | +$28.3K | ﹤0.01% | 2019 |
|
|
2023
Q3 | $157K | Buy |
+11,460
| New | +$157K | ﹤0.01% | 2239 |
|
|
2020
Q4 | – | Sell |
-1,642
| Closed | -$134K | – | 2820 |
|
|
2020
Q3 | $134K | Buy |
+1,642
| New | +$134K | ﹤0.01% | 1950 |
|